Business Tips

FDA Regulation of Nanotechnology | Harris Beach, PLLC

2/27/2012

Interested in the FDA’s regulatory impact on nanotechnology-based products?

Judi Abbott Curry, co-leader of the Harris Beach Medical and Life Sciences industry team, and Stanley Goos, co-leader of the Harris Beach Nanotechnology industry team co-authored a chapter entitled “Medical Devices” for an American Bar Association publication, “FDA Regulation of Nanotechnology.”

The publication includes an Introduction to FDA Regulation of Nanotechnology, as well as other chapters on various products, including, but not limited to Drugs (page 80), Biological Products (page 107), and Combination Products (page 118). Ms. Curry also edited the chapters on Drugs, Biological Products, and Combination Products. The Medical Devices chapter starts on page 94.

Click here to download the full publication.

Return to Previous Page